Hormonal therapies may cause treatment resistance in breast cancer

12 Dec 2018


Metastatic breast cancer treated with hormonal therapies can acquire mutations in HER2 and become treatment resistant, according to data published in Nature Genetics.    

MedicalXpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story